X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (276) 276
Publication (38) 38
Conference Proceeding (29) 29
Book Review (4) 4
Newspaper Article (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (130) 130
humans (125) 125
hematology (120) 120
transplantation (119) 119
female (106) 106
adult (105) 105
middle aged (105) 105
male (98) 98
immunology (83) 83
stem cells (74) 74
aged (70) 70
hematology, oncology and palliative medicine (63) 63
treatment outcome (51) 51
adolescent (50) 50
article (49) 49
young adult (49) 49
hematopoietic stem cell transplantation (48) 48
hematopoietic stem cells (47) 47
oncology (41) 41
retrospective studies (41) 41
transplantation, homologous (40) 40
bone-marrow-transplantation (39) 39
cancer (36) 36
analysis (32) 32
hematopoietic stem cell transplantation - methods (29) 29
leukemia (28) 28
survival analysis (28) 28
survival rate (28) 28
abridged index medicus (27) 27
chemotherapy (27) 27
versus-host-disease (26) 26
disease-free survival (25) 25
stem-cell transplantation (25) 25
survival (25) 25
care and treatment (24) 24
prognosis (24) 24
transplantation conditioning - methods (24) 24
mortality (22) 22
transplantation conditioning (22) 22
recurrence (21) 21
stem cell transplantation (21) 21
relapse (20) 20
therapy (20) 20
transplantation, autologous (20) 20
hematopoietic stem cell transplantation - adverse effects (19) 19
hemic and lymphatic diseases (19) 19
patient outcomes (19) 19
leukemia, myeloid, acute - therapy (18) 18
child (17) 17
follow-up studies (17) 17
graft vs host disease - etiology (17) 17
remission induction (17) 17
graft vs host disease - prevention & control (16) 16
multiple myeloma (16) 16
risk factors (16) 16
surgical procedures, operative (16) 16
vidarabine - analogs & derivatives (16) 16
busulfan (15) 15
health aspects (15) 15
hematologic neoplasms - therapy (15) 15
myelodysplastic syndromes - therapy (15) 15
acute myeloid-leukemia (14) 14
allergy (14) 14
fludarabine (14) 14
lymphomas (14) 14
melphalan (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
blood (13) 13
child, preschool (13) 13
cyclophosphamide (13) 13
leukemia, myeloid, acute - mortality (13) 13
risk (13) 13
vidarabine - administration & dosage (13) 13
allergy and immunology (12) 12
allogeneic stem cell transplantation (12) 12
allografts (12) 12
graft vs host disease - mortality (12) 12
hematologic malignancies (12) 12
myelodysplastic syndrome (12) 12
outcomes (12) 12
research (12) 12
aml (11) 11
hematologic neoplasms - mortality (11) 11
myelodysplastic syndromes - mortality (11) 11
t cells (11) 11
acute myelogenous leukemia (10) 10
acute myeloid leukemia (10) 10
allogeneic transplantation (10) 10
autologous transplantation (10) 10
busulfan - administration & dosage (10) 10
diseases (10) 10
hematopoietic stem cell transplantation - mortality (10) 10
high-dose chemotherapy (10) 10
immunotherapy (10) 10
patients (10) 10
recipients (10) 10
time factors (10) 10
usage (10) 10
adults (9) 9
bone marrow (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, pp. e60209 - e60209
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 09/2016, Volume 126, Issue 9, pp. 3363 - 3376
BACKGROUND. T cells expressing antigen-specific chimeric antigen receptors (CARs) improve outcomes for CD19-expressing B cell malignancies. We evaluated a... 
MEDICINE, RESEARCH & EXPERIMENTAL | CLINICAL-TRIAL | BONE-MARROW-TRANSPLANTATION | CHIMERIC-ANTIGEN-RECEPTOR | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKIN-LYMPHOMA | VERSUS-HOST-DISEASE | MINIMAL RESIDUAL DISEASE | HEMATOLOGIC MALIGNANCIES | ADOPTIVE IMMUNOTHERAPY | ANTITUMOR EFFICACY | Immunotherapy, Adoptive - methods | Cytokines - metabolism | Follow-Up Studies | Receptors, Antigen, T-Cell - metabolism | Humans | Middle Aged | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Antigen-Presenting Cells - immunology | Plasmids - metabolism | DNA Transposable Elements | Transplantation, Homologous | Young Adult | Disease-Free Survival | Lymphocyte Activation - immunology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | T-Lymphocytes - cytology | Lymphoma, Non-Hodgkin - therapy | Patient Safety | Adult | Female | Antigens, CD19 - metabolism | Genetic Therapy - methods | Cell receptors | Transplantation | Genetic aspects | Health aspects | Patient outcomes | Hematopoietic stem cells | Medical research | Cytokines | Genes | Cloning | Leukemia | Clinical trials | Principal components analysis | T cell receptors | Cancer therapies | Studies | Plasmids | Lymphocytes | Immunotherapy | Genetic engineering | Lymphomas | Design of experiments | Deoxyribonucleic acid--DNA | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 24, pp. 2305 - 2315
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 133, Issue 4, pp. 1026 - 1031
Journal Article
Kriminologisches Journal, ISSN 0341-1966, 2016, Volume 48, Issue 4, pp. 259 - 271
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S32 - S33
Fluid overload (FO) grade [greater than or equal to] 2 (more that 10% weight gain from baseline) has recently been recognized as an important toxicity... 
Transplantation | Comorbidity | Analysis | Mortality | Stem cells | Endothelium
Journal Article